+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acute Care Syndromic Testing Market by Syndromic Panel (Central Nervous System, Gastrointestinal, Respiratory), Product Type (Instruments, Kits Reagents, Software Services), End User, Technology, Application - Global Forecast 2025-2030- Product Image
Acute Care Syndromic Testing Market by Syndromic Panel (Central Nervous System, Gastrointestinal, Respiratory), Product Type (Instruments, Kits Reagents, Software Services), End User, Technology, Application - Global Forecast 2025-2030- Product Image
Sale

Acute Care Syndromic Testing Market by Syndromic Panel (Central Nervous System, Gastrointestinal, Respiratory), Product Type (Instruments, Kits Reagents, Software Services), End User, Technology, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924822
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Acute care syndromic testing is becoming a cornerstone for modern healthcare leaders seeking improved clinical outcomes and operational efficiency. By enabling simultaneous pathogen identification with streamlined workflows, this market empowers rapid decision-making in high-acuity environments.

Market Snapshot: Acute Care Syndromic Testing Market Overview

The Acute Care Syndromic Testing Market grew from USD 3.74 billion in 2024 to USD 4.12 billion in 2025. It is expected to continue growing at a CAGR of 10.02%, reaching USD 6.64 billion by 2030. This robust expansion illustrates strong demand among hospitals, laboratories, and public health agencies for multiplex diagnostic solutions that offer speed, accuracy, and broad pathogen detection at the point of care. Multiple factors—including growing infection complexity, stewardship requirements, and data integration needs—are contributing to rapid adoption rates across various geographical regions and healthcare settings.

Scope & Segmentation: In-Depth Acute Care Syndromic Testing Analysis

  • Syndromic Panel Categories: Central nervous system (encephalitis, meningitis), gastrointestinal (bacterial, parasitic, viral), respiratory (bacterial, viral, combined), sexually transmitted infection (Chlamydia, Gonorrhea, Herpes)
  • Product Types: Benchtop instruments, point-of-care analyzers, cartridges, multiplex assay kits, reagents, data management platforms, service contracts
  • End Users: Hospitals, academic research institutes, public health laboratories, reference laboratories
  • Technology Choices: Mass spectrometry, microarray, multiplex PCR, next-generation sequencing, qPCR
  • Applications: Differential diagnosis, epidemiology, outbreak investigation, research, surveillance
  • Regional Coverage: Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Players: bioMérieux SA, Cepheid Inc., Roche Holding AG, QIAGEN N.V., Luminex Corporation, Becton Dickinson and Company, Hologic Inc., Seegene Inc., Quidel Corporation, Abbott Laboratories

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Syndromic testing is reshaping acute care protocols by reducing diagnostic turnaround times and enabling simultaneous detection of multiple infectious agents.
  • Integration with electronic health record systems supports data-driven patient triage, enhances antimicrobial stewardship, and enables more targeted therapy selection.
  • Automated technologies and data analytics increase throughput and reliability, making large-scale adoption across diverse laboratory environments feasible.
  • Point-of-care platforms accelerate decentralization, but require investment in quality control processes and ongoing staff training.
  • Segmented product offerings—from instruments through service contracts—allow tailored procurement strategies matched to clinical infrastructure and operational capacity.
  • Collaborative partnerships are driving innovation, from bioinformatics software advances to streamlined workflow solutions, helping organizations adapt to evolving disease landscapes and regulatory pressures.

Tariff Impact: Evolving U.S. Trade Policies

Recent U.S. tariffs on specialized raw materials and instruments have prompted manufacturers to reassess global sourcing strategies and invest in domestic production to ensure resilient supply chains. Laboratories and procurement teams now navigate new pricing models, longer lead times, and the need to maintain compliance with regulatory standards when adopting substitute products. These developments highlight the growing importance of agile purchasing models and cross-team collaboration to safeguard consistent access to validated syndromic testing solutions.

Methodology & Data Sources

Insights stem from a combination of primary expert interviews—including laboratory directors, microbiologists, and procurement specialists—and extensive secondary research across peer-reviewed literature, regulatory publications, white papers, and proprietary databases. Competitive intelligence is based on public filings, press releases, and patent analysis, reinforced through data triangulation and market expert validation.

Why This Report Matters

  • Provides healthcare leaders and manufacturers with a comprehensive understanding of acute care syndromic testing trends, supporting informed investment and operational decision-making.
  • Delivers actionable strategies for adapting diagnostic workflows, managing supply chain risks, and navigating regulatory frameworks in rapidly changing global markets.
  • Identifies competitive advantages and partnership opportunities that drive sustainable growth, improved patient outcomes, and more robust public health preparedness.

Conclusion

Acute care syndromic testing is evolving into a critical enabler of efficient, data-driven diagnostics in modern healthcare. By leveraging innovative platforms and adaptive procurement, organizations are better positioned to address emerging infectious threats and optimize patient management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of multiplex PCR respiratory panels for rapid pathogen identification in emergency departments
5.2. Integration of AI-driven algorithms with syndromic testing platforms to accelerate diagnosis and predictive analytics
5.3. Expansion of syndromic testing panels to include emerging antimicrobial resistance markers for hospital stewardship
5.4. Regulatory and reimbursement shifts influencing adoption of point-of-care molecular syndromic tests in acute settings
5.5. Increasing use of next-generation sequencing in hospital syndromic surveillance to detect microbial outbreaks faster
5.6. Vendor consolidation and strategic partnerships driving standardization and cost efficiencies in multiplex acute care testing
5.7. Advancements in integrated digital health platforms enabling real-time syndromic data sharing across hospital networks
5.8. Shift toward decentralized point-of-care molecular diagnostics to reduce time to actionable acute care decisions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Acute Care Syndromic Testing Market, by Syndromic Panel
8.1. Introduction
8.2. Central Nervous System
8.2.1. Encephalitis
8.2.2. Meningitis
8.3. Gastrointestinal
8.3.1. Bacterial
8.3.2. Parasitic
8.3.3. Viral
8.4. Respiratory
8.4.1. Bacterial
8.4.2. Combined
8.4.3. Viral
8.5. Sexually Transmitted Infection
8.5.1. Chlamydia Gonorrhea
8.5.2. Herpes
9. Acute Care Syndromic Testing Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. Benchtop
9.2.2. Point Of Care
9.3. Kits Reagents
9.3.1. Cartridges
9.3.2. Multiplex Assay Kits
9.3.3. Reagents
9.4. Software Services
9.4.1. Data Management
9.4.2. Service Contracts
10. Acute Care Syndromic Testing Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Hospitals
10.4. Public Health Laboratories
10.5. Reference Laboratories
11. Acute Care Syndromic Testing Market, by Technology
11.1. Introduction
11.2. Mass Spectrometry
11.3. Microarray
11.4. Multiplex Pcr
11.5. Ngs
11.6. Qpcr
12. Acute Care Syndromic Testing Market, by Application
12.1. Introduction
12.2. Differential Diagnosis
12.3. Epidemiology
12.4. Outbreak Investigation
12.5. Research
12.6. Surveillance
13. Americas Acute Care Syndromic Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Acute Care Syndromic Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Acute Care Syndromic Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. bioMérieux SA
16.3.2. Cepheid, Inc.
16.3.3. Roche Holding AG
16.3.4. QIAGEN N.V.
16.3.5. Luminex Corporation
16.3.6. Becton Dickinson and Company
16.3.7. Hologic, Inc.
16.3.8. Seegene, Inc.
16.3.9. Quidel Corporation
16.3.10. Abbott Laboratories
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ACUTE CARE SYNDROMIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ACUTE CARE SYNDROMIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ACUTE CARE SYNDROMIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ACUTE CARE SYNDROMIC TESTING MARKET: RESEARCHAI
FIGURE 26. ACUTE CARE SYNDROMIC TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. ACUTE CARE SYNDROMIC TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. ACUTE CARE SYNDROMIC TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ACUTE CARE SYNDROMIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ENCEPHALITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ENCEPHALITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MENINGITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COMBINED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COMBINED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CHLAMYDIA GONORRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CHLAMYDIA GONORRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HERPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HERPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BENCHTOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CARTRIDGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SERVICE CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SERVICE CONTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY NGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY NGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DIFFERENTIAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DIFFERENTIAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY OUTBREAK INVESTIGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY OUTBREAK INVESTIGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 162. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 163. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 164. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 165. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 166. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 167. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 168. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 169. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 170. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 171. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 174. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 175. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 176. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 177. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 178. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 179. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 186. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 187. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 188. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 194. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Acute Care Syndromic Testing market report include:
  • bioMérieux SA
  • Cepheid, Inc.
  • Roche Holding AG
  • QIAGEN N.V.
  • Luminex Corporation
  • Becton Dickinson and Company
  • Hologic, Inc.
  • Seegene, Inc.
  • Quidel Corporation
  • Abbott Laboratories

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.64 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Acute Care Syndromic Testing Global Market Report 2025 - Product Image

Acute Care Syndromic Testing Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization - Product Image

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

  • Report
  • 501 Pages
  • Global
From
Syndromic Multiplex Diagnostics - Global Strategic Business Report - Product Image

Syndromic Multiplex Diagnostics - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030 - Product Image

Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.